
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4771871
[patent_doc_number] => 20080057529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Method for Identifying Histone Deacetylase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/582621
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17446
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057529.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582621 | Method for Identifying Histone Deacetylase Inhibitors | Dec 9, 2004 | Abandoned |
Array
(
[id] => 5079652
[patent_doc_number] => 20070122876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Nucleic acids for enhancing gene expression and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/006817
[patent_app_country] => US
[patent_app_date] => 2004-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12699
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11006817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/006817 | Nucleic acids for enhancing gene expression and use thereof | Dec 7, 2004 | Issued |
Array
(
[id] => 8759876
[patent_doc_number] => 08420395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same'
[patent_app_type] => utility
[patent_app_number] => 11/003941
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 90333
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11003941
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003941 | Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same | Dec 2, 2004 | Issued |
Array
(
[id] => 8527619
[patent_doc_number] => 08304189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Nucleic acid molecules containing recombination sites and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/000371
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 18
[patent_no_of_words] => 45661
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11000371
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000371 | Nucleic acid molecules containing recombination sites and methods of using the same | Nov 30, 2004 | Issued |
Array
(
[id] => 4899342
[patent_doc_number] => 20080118956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Viral Particles Containing An Alphavirus-Derived Vector And Method For Preparing Said Viral Particle'
[patent_app_type] => utility
[patent_app_number] => 10/581401
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5546
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581401
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581401 | Viral Particles Containing An Alphavirus-Derived Vector And Method For Preparing Said Viral Particle | Nov 29, 2004 | Abandoned |
Array
(
[id] => 8689957
[patent_doc_number] => 08389484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Methods for targeting RNA molecules'
[patent_app_type] => utility
[patent_app_number] => 10/999171
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 18883
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10999171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999171 | Methods for targeting RNA molecules | Nov 28, 2004 | Issued |
Array
(
[id] => 7019425
[patent_doc_number] => 20050221444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Methods and DNA constructs for high yield production of polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/997078
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27113
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997078
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997078 | Methods and DNA constructs for high yield production of polypeptides | Nov 23, 2004 | Issued |
Array
(
[id] => 7050779
[patent_doc_number] => 20050186666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Protein expression systems'
[patent_app_type] => utility
[patent_app_number] => 10/994138
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 37500
[patent_no_of_claims] => 215
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994138 | Protein expression systems | Nov 18, 2004 | Abandoned |
Array
(
[id] => 4970717
[patent_doc_number] => 20070110719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Novel use of adenoviruses and nucleic acids that code for said viruses'
[patent_app_type] => utility
[patent_app_number] => 10/579507
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 29981
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110719.pdf
[firstpage_image] =>[orig_patent_app_number] => 10579507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/579507 | Novel use of adenoviruses and nucleic acids that code for said viruses | Nov 14, 2004 | Abandoned |
Array
(
[id] => 7097214
[patent_doc_number] => 20050129672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Regulatory sequences that direct gene expression to spinal motor neurons and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/984406
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9413
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10984406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/984406 | Regulatory sequences that direct gene expression to spinal motor neurons and uses thereof | Nov 8, 2004 | Issued |
Array
(
[id] => 7252135
[patent_doc_number] => 20050142540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Methods and reagents for molecular detection of HIV-1 groups M, N and O'
[patent_app_type] => utility
[patent_app_number] => 10/980660
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11023
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142540.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980660 | Methods and reagents for molecular detection of HIV-1 groups M, N and O | Nov 2, 2004 | Abandoned |
Array
(
[id] => 6944788
[patent_doc_number] => 20050196837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Artificial mammalian chromosome'
[patent_app_type] => utility
[patent_app_number] => 10/972786
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16424
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 53
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196837.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972786 | Artificial mammalian chromosome | Oct 25, 2004 | Abandoned |
Array
(
[id] => 5903269
[patent_doc_number] => 20060046293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Dopaminergic Nurr1-positive neuron stem cells, pharmaceutical composition therefor, and methods for isolation, culture and preservation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/974273
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 3271
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20060046293.pdf
[firstpage_image] =>[orig_patent_app_number] => 10974273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/974273 | Dopaminergic Nurr1-positive neuron stem cells, pharmaceutical composition therefor, and methods for isolation, culture and preservation thereof | Oct 25, 2004 | Abandoned |
Array
(
[id] => 7074725
[patent_doc_number] => 20050147993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Methods and compositions for delivering polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/972963
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20159
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10972963
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/972963 | Methods and compositions for delivering polynucleotides | Oct 24, 2004 | Issued |
Array
(
[id] => 6958574
[patent_doc_number] => 20050214944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'In vivo homologous sequence targeting in cells'
[patent_app_type] => utility
[patent_app_number] => 10/973209
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 33910
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10973209
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/973209 | In vivo homologous sequence targeting in cells | Oct 24, 2004 | Abandoned |
Array
(
[id] => 7196733
[patent_doc_number] => 20050164370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Transformed cell co-expressing cytokinin receptor and cytokinin biosynthesis enzyme'
[patent_app_type] => utility
[patent_app_number] => 10/960929
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18478
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10960929
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/960929 | Transformed cell co-expressing cytokinin receptor and cytokinin biosynthesis enzyme | Oct 11, 2004 | Abandoned |
Array
(
[id] => 6939166
[patent_doc_number] => 20050112729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Recombinant DNA having hydantoinase gene and carbamylase gene and process for producing amino acid'
[patent_app_type] => utility
[patent_app_number] => 10/961116
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11906
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112729.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961116 | Recombinant DNA having hydantoinase gene and carbamylase gene and process for producing amino acid | Oct 11, 2004 | Abandoned |
Array
(
[id] => 10040310
[patent_doc_number] => 09081011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt'
[patent_app_type] => utility
[patent_app_number] => 10/575217
[patent_app_country] => US
[patent_app_date] => 2004-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 74
[patent_no_of_words] => 14870
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10575217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575217 | Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt | Oct 7, 2004 | Issued |
Array
(
[id] => 6990964
[patent_doc_number] => 20050090001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Cell lines and methods for producing proteins'
[patent_app_type] => utility
[patent_app_number] => 10/960169
[patent_app_country] => US
[patent_app_date] => 2004-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10113
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10960169
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/960169 | Cell lines and methods for producing proteins | Oct 6, 2004 | Abandoned |
Array
(
[id] => 4475739
[patent_doc_number] => 07906111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/573600
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 128
[patent_no_of_words] => 25782
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906111.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573600
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573600 | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor | Sep 29, 2004 | Issued |